Abstract:The liver is the main metabolic organ and functions to regulate many physiological functions in the human body. Approximately 70% of liver mass consists of hepatic cells (hepatocytes), which execute the liver's metabolic processes. When liver damage progresses to a chronic condition, such as end-stage liver disease (ESLD) or cirrhosis of the liver, the patient's only option for therapy is organ transplantation if the supply of available transplanted organs is insufficient to meet the patient's needs. The fundamental objective of the search for alternatives to organ transplantation has been to make liver tissue replacement more accessible and to produce hepatic and bioartificial liver tissue. Multiple hepatic cell lineages can be formed from human-induced pluripotent stem cells (hiPSCs) from embryoid bodies to become mature hepatocytes. hiPSCs also show a promising source for manufacturing human liver spheroids and are made to produce three-dimensional hepatobiliary organoids, and in some ways, it also briefly highlights important features of early hepatogenesis. Unquestionably, the art of cell culture has evolved to include the use of organoid technology as a resource for learning human biology in the context of health and illness. Organoids are essentially miniature organs that can grow in a three-dimensional matrix to resemble genuine organs in terms of both structure and function. This review summarized alternative protocols to differentiate hepatocytes from iPSC and to produce liver organoids based on iPSC in various ways. The growth of human iPSCs into liver organoids has been accomplished using several procedures.

Progress, Application and Challenges of Liver Organoids

Liver Organoids: Established Tools for Disease Modeling and Drug Development

Liver Organoids: Formation Strategies and Biomedical Applications

Advances and Applications in Liver Organoid Technology

Liver organoids and their application in liver cancer research

Research progress and application of liver organoids for disease modeling and regenerative therapy

Liver organoids: updates on generation strategies and biomedical applications

The liver organoid's past, present and future: a personalized medicine strategy

Human liver organoids: From generation to applications

Liver Organoids, Novel and Promising Modalities for Exploring and Repairing Liver Injury

A decade of liver organoids: Advances in disease modeling

Using Liver Organoids as Models to Study the Pathobiology of Rare Liver Diseases

Insight to Biofabrication of Liver Microtissues for Disease Modeling: Challenges and Opportunities

Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer

Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening

Induced Pluripotent Stem Cells (Ipscs) Based Liver Organoid: the Benefits and Challenges

Hepatobiliary Organoids and Their Applications for Studies of Liver Health and Disease: Are We There Yet?

Organoid As a Promising Tool for Primary Liver Cancer Research: a Comprehensive Review

Primary liver cancer organoids and their application to research and therapy

iPSC-Derived Liver Organoids: A Journey from Drug Screening, to Disease Modeling, Arriving to Regenerative Medicine